Anven Team

 
Anven Rusty Williams.png

Lewis T. "Rusty" Williams | MD, PhD

Co-Founder and Chairman

  • Founder of Walking Fish Therapeutics, Five Prime Therapeutics and COR Therapeutics

  • Chief Scientific Officer & board member of Chiron Corporation (now Novartis Vaccines and Diagnostics, Inc.)

  • Professor of medicine, UCSF and director of Cardiovascular Research Institution and Daiichi Research Center. Also served on the faculties of Harvard Medical School and Massachusetts General Hospital

  • Member of National Academy of Sciences and fellow of the American Academy of Arts and Sciences

  • B.S. Rice University; M.D./Ph.D. Duke University

 
Anven Reddy Moola.png

muralidhar Reddy Moola | PHD

Co-Founder, Board Director and CEO

  • Assoc. Prof. of chemistry, The Scripps Research Institute; Asst. Prof. of internal medicine, UT Southwestern Medical Center

  • Published and patented > 50 novel small molecule and  peptoid-based technologies

  • Inventor of the Anven’s core technology platform

  • PhD from Indian Institute of Chemical Technology 

 
Anven Bill Shelander.png

Bill Shelander | MSE, MBA

Co-Founder, Board Director and COO

  • Faculty of Stanford University and Haas School of Business, UC Berkeley

  • 30+ years of VC management and start ups in advanced technologies

  • Commercialization expert at Lawrence Berkeley National Lab

  • MBA from Stanford University; MS in Chemical Engineering

 

Ronald Zuckermann | PhD

Co-Founder, Board Director, and Member of the Scientific Advisory Board

  • Director of Biological Nanostructures, Lawrence Berkeley National Lab    http://www.ronznet.com

  • Invented class of heteropolymers called "Peptoids“ in early 1990’s

  • A founding chemist at Protos Corp. (drug discovery venture)

  • PhD from UC Berkeley in Bioorganic Chemistry with Dr. Peter Schultz; published >170 papers, 38 patents

 
mike new 4.png

Michael Weiner | MD

Chairman of the Scientific Advisory Board

  • Professor of Radiology and Biomedical Engineering, Medicine, Psychiatry and Neurobiology at the University of California, San Francisco

  • Principle Investigator of Alzheimer's Disease Neuroimaging Initiative (ADNI), the largest observational study in the world for Alzheimer’s disease

  • Director, Center for Imaging of Neurodegenerative Diseases, UCSF VA Medical Center, San Francisco, California

  • Published >900 articles and 70 book chapters. Link http://profiles.ucsf.edu/michael.weiner

  • B.S. Johns Hopkins University; M.D. SUNY Medical Center; Fellowship at Yale University School of Medicine

 

NITIN PAREKH | PhD

Scientific and Business Advisory Board

  • VP/Exec. Director at SK biotek; served on boards of Vybion, Inc, New Jersey Inst. of Tech., and South Carolina biotechnology program

  • Senior management positions in DSM, Pharmacia-Upjohn (Pfizer), Monsanto, Hoechst, and Boehringer-Knoll

  • 30+ years of drug development, M&A, R&D and manufacturing with technology valuation and implementation

  • PhD from Boston college and visiting faculty of MIT